What’s new at CRO

Date
Oct 11, 2018

BioJapan 2018 World Business Forum

Teaser text

BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades.
Date
Aug 14, 2018

Completion of recruitment for a Phase I MS trial

Teaser text
Recently we finished recruiting for a Phase I trial in patients with progressive multiple sclerosis. This randomized, double-blind, placebo-controlled study was designed to assess the safety and tolerability of a new biologic as well as the pharmacodynamics...
Date
Jun 23, 2018

MAD/Phase IIa T2D study publication available

Teaser text
As of today you can access a new paper published in The Lancet on 22 June 2018 on a combined multiple-ascending dose (MAD) and Phase IIa study in n=112 patients with controlled type 2 diabetes (HbA1c levels between 6.5–8.5%) via...